Fluids and vein congestion in heart ICU patients
Part of Heart & circulation clinical trials.
This trial studies how giving fluids affects blood buildup in the veins of critically ill heart patients in the ICU. It may help doctors decide how much fluid to give.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are admitted to a cardiac intensive care unit
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how tiny blood vessels respond to extra fluids in ICU patients who have vein congestion. It helps doctors understand if giving more fluid is helpful or harmful for you.
This trial looks at how well your body responds to extra fluids given through an IV, and whether it helps your veins. It is for people in the ICU who already have heart monitoring in place.
This trial uses ultrasound to check for fluid buildup in veins of patients in the intensive care unit. It aims to see if this technique can help doctors manage treatment better.
This study watches how the right side of your heart responds when doctors give you extra fluids to improve blood flow during a critical illness. Understanding this response may help doctors make better decisions about fluid treatment in the ICU.
This trial tests if using a special ultrasound score (VeXUS) to guide fluid removal can improve recovery in patients with acute kidney injury after heart surgery. It compares this approach to standard care to see if it leads to better outcomes.
This trial tests whether using ultrasound imaging of your veins and measuring salt in your urine can help doctors give you the right amount of IV diuretics (water pills) when you're hospitalized for heart failure. The goal is to improve your symptoms and recovery.
Hear when a new Cardiac Anaesthesia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.